Anatomy of the Heart: Intercostal Spaces and Auscultation Positions

The human heart is a vital organ responsible for pumping blood throughout the body. Understanding its anatomy is crucial for medical professionals to diagnose and treat various heart conditions. In this article, we will discuss the intercostal spaces and auscultation positions related to the heart.

Left Fifth Intercostal Space: Apex of the Heart
The apex of the heart is located deep to the left fifth intercostal space, approximately 8-9 cm from the mid-sternal line. This is an important landmark for cardiac examination and procedures.

Left Fourth Intercostal Space: Left Ventricle
The left ventricle, one of the four chambers of the heart, is located superior to the apex and can be auscultated in the left fourth intercostal space.

Right Fourth Intercostal Space: Right Atrium
The right atrium, another chamber of the heart, is located immediately lateral to the right sternal margin at the right fourth intercostal space.

Left Second Intercostal Space: Pulmonary Valve
The pulmonary valve, which regulates blood flow from the right ventricle to the lungs, can be auscultated in the left second intercostal space, immediately lateral to the left sternal margin.

Right Fifth Intercostal Space: Incorrect Location
The right fifth intercostal space is an incorrect location for cardiac examination because the apex of the heart is located on the left side.

In conclusion, understanding the intercostal spaces and auscultation positions related to the heart is essential for medical professionals to accurately diagnose and treat various heart conditions.

Treatment Options for a Patient with Narrow-Complex Tachycardia and Low Blood Pressure

When a patient with a history of ischaemic heart disease presents with a narrow-complex tachycardia and low blood pressure, it is likely that they have gone into fast atrial fibrillation. In this case, the first step in resuscitation should be a synchronised direct current (DC) cardioversion with a 150-J biphasic shock. Administering 100% oxygen, a 500 ml Hartmann bolus, and 0.5 mg metaraminol may help increase the patient’s blood pressure, but it does not address the underlying cause of their haemodynamic instability.

Amiodarone 300 mg stat is recommended for patients with narrow-complex tachycardia and haemodynamic instability. However, administering 10 mmol magnesium sulphate is not the first-line treatment for tachycardia unless the patient has torsades de pointes.

Lastly, administering Intralipid® as per guideline for local anaesthetic toxicity is unlikely to be the main source of the patient’s hypotension and does not address their narrow-complex tachycardia. Therefore, it is important to prioritize the synchronised cardioversion and amiodarone administration in this patient’s treatment plan.

Common Heart Murmurs and their Characteristics

Heart murmurs are abnormal sounds heard during the cardiac cycle. They can be caused by a variety of conditions, including valve disorders. Here are some common heart murmurs and their characteristics:

Tricuspid Regurgitation: This condition leads to an elevated jugular venous pressure (JVP) with large V-waves and a pan-systolic murmur at the left sternal edge. Other features include pulsatile hepatomegaly and left parasternal heave.

Tricuspid Stenosis: Tricuspid stenosis causes a mid-diastolic murmur heard best at the left sternal border.

Pulmonary Stenosis: Pulmonary stenosis causes an ejection systolic murmur in the second left intercostal space.

Mitral Regurgitation: Mitral regurgitation causes a pan-systolic murmur at the apex, which radiates to the axilla.

Mitral Stenosis: Mitral stenosis causes a mid-diastolic murmur at the apex, and severe cases may have secondary pulmonary hypertension (a cause of tricuspid regurgitation).

Knowing the characteristics of these murmurs can aid in their diagnosis and management. It is important to consult with a healthcare professional if you suspect you may have a heart murmur.

Differential Diagnosis: Cor Pulmonale vs. Other Conditions

Cor pulmonale, or right ventricular failure due to pulmonary heart disease, is the most likely diagnosis for a patient presenting with symptoms such as wheeze, increasing fatigue, and pitting edema. The patient’s history of taking drugs known to cause pulmonary fibrosis, such as methotrexate and nitrofurantoin, supports this diagnosis. Aortic stenosis, asthma, COPD, and left ventricular failure are all possible differential diagnoses, but each has distinguishing factors that make them less likely. Aortic stenosis would not typically present with peripheral edema, while asthma and COPD do not fit with the patient’s lack of risk factors and absence of certain symptoms. Left ventricular failure is also less likely due to the absence of signs such as decreased breath sounds and S3 gallop on heart auscultation. Overall, cor pulmonale is the most likely diagnosis for this patient.

Common Congenital Heart Defects and their Characteristics

An endocardial cushion defect, also known as an AVSD, is the most prevalent cardiac malformation in individuals with Down Syndrome. This defect can lead to irreversible pulmonary hypertension, which is known as Eisenmenger’s syndrome. It is unclear why children with Down Syndrome tend to have more severe cardiac disease than unaffected children with the same abnormality.

ASDs, or atrial septal defects, may close on their own, and the likelihood of spontaneous closure is related to the size of the defect. If the defect is between 5-8 mm, there is an 80% chance of closure, but if it is larger than 8 mm, the chance of closure is minimal.

Tetralogy of Fallot, a cyanotic congenital heart disease, typically presents after three months of age. The murmur of VSD, or ventricular septal defect, becomes more pronounced after one month of life. Overall, the characteristics of these common congenital heart defects is crucial for proper diagnosis and treatment.

Cusps and Papillary Muscles of the Heart Valves

The heart valves play a crucial role in regulating blood flow through the heart. The tricuspid and mitral valves are located between the atria and ventricles of the heart. These valves have cusps, which are flaps of tissue that open and close to allow blood to flow in one direction. The papillary muscles, located in the ventricles, attach to the cusps of the valves and help to control their movement.

Tricuspid Valve:
The tricuspid valve has three cusps: anterior, posterior, and septal. The anterior and posterior cusps are attached to the anterior and posterior papillary muscles, respectively. The septal cusp is attached to the septal papillary muscle.

Mitral Valve:
The mitral valve has two cusps: anterior and posterior. These cusps are not attached to papillary muscles directly, but rather to chordae tendineae, which are thin tendons that connect the cusps to the papillary muscles.

Understanding the anatomy of the heart valves and their associated papillary muscles is important for diagnosing and treating heart conditions such as valve prolapse or regurgitation.

Complications of Myocardial Infarction

Myocardial infarction can lead to various complications, including Dressler syndrome, papillary muscle rupture, ventricular aneurysm, reinfarction, and pericardial tamponade. Dressler syndrome is a delayed complication that occurs weeks after the initial infarction and is caused by autoantibodies against cardiac antigens released from necrotic myocytes. Symptoms include mild fever, pleuritic chest pain, and a friction rub. Papillary muscle rupture occurs early after a myocardial infarction and presents with acute congestive heart failure and a new murmur of mitral regurgitation. Ventricular aneurysm is characterized by paradoxical wall motion of the left ventricle and can lead to stasis and embolism. Reinfarction is less likely in a patient with atypical symptoms and no rising troponin. Pericardial tamponade is a rare complication of Dressler syndrome and would present with raised JVP and muffled heart sounds.

Treatment Options for Pulmonary Hypertension

Pulmonary hypertension (PAH) is a condition that can cause shortness of breath, weakness, and tiredness. A high-pitched decrescendo murmur may indicate pulmonary regurgitation and PAH. Diuretics can help reduce the pressure on the right ventricle and remove excess fluid. Oxygen therapy can improve exercise tolerance, and bosentan can slow the progression of PAH by inhibiting vasoconstriction. Salbutamol and ipratropium inhalers are appropriate for COPD, but not for PAH. Salbutamol nebulizer and supplemental oxygen are appropriate for acute exacerbations of asthma or COPD, but not for PAH. Aortic valve replacement is not indicated for PAH. Antiplatelets may be helpful for reducing the risk of thrombosis. Increasing bisoprolol may be helpful for atrial flutter, but not for PAH. High-dose calcium-channel blockers may be used for PAH with right heart failure under senior supervision/consultation.

Eruptive Xanthoma and its Association with Hypertriglyceridaemia and Diabetes Mellitus

Eruptive xanthoma is a skin condition that can occur in individuals with hypertriglyceridaemia and uncontrolled diabetes mellitus. Hypertriglyceridaemia is a condition characterized by high levels of triglycerides in the blood, which can be caused by a number of factors including genetics, diet, and lifestyle. Eruptive xanthoma is a type of xanthoma that appears as small, yellowish bumps on the skin, often in clusters.

Of the conditions listed, familial hypertriglyceridaemia is the most likely to be associated with eruptive xanthoma. This is a genetic condition that causes high levels of triglycerides in the blood, and can lead to a range of health problems including cardiovascular disease. Uncontrolled diabetes mellitus, which is characterized by high blood sugar levels, can also be a risk factor for eruptive xanthoma.

It is important for individuals with hypertriglyceridaemia or diabetes mellitus to manage their condition through lifestyle changes and medication, in order to reduce the risk of complications such as eruptive xanthoma. Regular monitoring and treatment can help to prevent the development of this skin condition and other related health problems.

Treatment Options for Ventricular Tachycardia: Synchronised Cardioversion and Amiodarone

Ventricular tachycardia is a serious condition that requires immediate treatment. The Resuscitation Council tachycardia guideline recommends synchronised electrical cardioversion as the first-line treatment for unstable patients with ventricular tachycardia who exhibit adverse features such as shock, myocardial ischaemia, syncope, or heart failure. Synchronised cardioversion is timed to coincide with the R or S wave of the QRS complex, reducing the risk of ventricular fibrillation or cardiac arrest.

Administering an unsynchronised shock could coincide with the T wave, triggering fibrillation of the ventricles and leading to a cardiac arrest. If three attempts of synchronised cardioversion fail to restore sinus rhythm, a loading dose of amiodarone 300 mg iv should be given over 10–20 minutes, followed by another attempt of cardioversion.

Amiodarone is the first-line treatment for uncompromised patients with tachycardia. A loading dose of 300 mg is given iv, followed by an infusion of 900 mg over 24 hours. Digoxin and metoprolol are not recommended for the treatment of ventricular tachycardia. Digoxin is used for atrial fibrillation, while metoprolol should be avoided in patients with significant hypotension, as it can further compromise the patient’s condition.